Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
05:11:40 EDT Mon 06 May 2024
Enter Symbol
or Name
USA
CA



News for U:ORGS from 2023-05-07 to 2024-05-06 - 26 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-15 17:07U:ORGSNews ReleaseOrgenesis Provides Year End Business Update
2024-04-10 12:00U:ORGSNews ReleaseGermfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility
2024-03-18 08:30U:ORGSNews ReleaseVered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference
2024-03-13 08:30U:ORGSNews ReleaseOrgenesis Consortium Awarded euros1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes
2024-03-04 08:30U:ORGSNews ReleaseOrgenesis Inc. Announces $2.3 Million Private Placement
2024-02-29 08:30U:ORGSNews ReleaseOrgenesis Consortium Awarded euros2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing
2024-01-31 09:15U:ORGSNews ReleaseOrgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to Clinic
2023-11-14 08:30U:ORGSNews ReleaseOrgenesis Ranked No. 171st Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 TM
2023-11-13 16:16U:ORGSNews ReleaseOrgenesis Provides Business Update for the Third Quarter of 2023
2023-11-08 09:00U:ORGSNews ReleaseOrgenesis Inc. Announces Pricing of $1.1 Million Registered Direct Offering
2023-11-02 08:00U:ORGSNews ReleaseOrgenesis Announces Expanded Partnership Between Octomera and UC Davis Through CIRM Grant Funding
2023-10-30 21:30U:ORGSNews ReleaseOrgenesis Announces Withdrawal of Proposed Public Offering
2023-10-30 16:07U:ORGSNews ReleaseOrgenesis Announces Proposed Underwritten Public Offering
2023-09-21 08:00U:ORGSNews ReleaseCGT Global and Octomera Enter Agreement to Expand ‚  Cell & Gene Therapy Development and Patient Access Across the United States
2023-09-06 07:00U:ORGSNews ReleaseCell and Gene Therapy Industry Pioneer & GMP Expert, Gerhard Bauer, Joins Orgenesis Business, Octomera, to Drive Continued Expansion of POCare Facilities and Service Support
2023-08-11 07:00U:ORGSNews ReleaseOrgenesis Provides Business Update for Second Quarter of 2023
2023-08-10 08:30U:ORGSNews ReleaseOrgenesis Schedules Second Quarter 2023 Business Update Conference Call
2023-07-13 08:30U:ORGSNews ReleaseOrgenesis Appoints Finance Veteran Elliot Maltz as its Chief Financial Officer
2023-07-11 07:00U:ORGSNews ReleaseOrgenesis Announces Name Change of Morgenesis Business Unit to Octomera
2023-06-07 07:00U:ORGSNews ReleaseOrgenesis and University of California, Davis Sign Partnership Agreement for Rollout of Cell and Gene Therapy Mobile Processing Units and Labs Throughout California
2023-05-30 09:30U:ORGSNews ReleaseClaudia Zylberberg Appointed as Independent Board Member of POCare Business Subsidiary of Orgenesis
2023-05-22 07:30U:ORGSNews ReleaseOrgenesis Academy Graduates First Class of Cell and Gene Therapy Experts from theraCell Laboratories-backed Master ¢ € ™s Program
2023-05-19 08:30U:ORGSNews ReleaseOrgenesis to Participate in Benchmark ¢ € ™s 3rd Annual Healthcare House Call Virtual 1x1 Investor Conference on May 23, 2023
2023-05-18 07:30U:ORGSNews ReleaseOrgenesis Announces Collaboration Agreement with SCTbio to Expand POCare Sites in the Czech Republic and Enhance Capabilities for the Production of Lentivirus Vectors
2023-05-10 16:30U:ORGSNews ReleaseOrgenesis Provides Business Update for the First Quarter of 2023 and Reports Continued Progress on its POCare Strategy
2023-05-10 10:00U:ORGSNews ReleaseOrgenesis Secures an Additional $5 Million Investment from Metalmark Capital to Accelerate Growth of Point-of-Care Service Subsidiary